DE60138703D1 - Transportpeptide abgeleitet von erns protein - Google Patents

Transportpeptide abgeleitet von erns protein

Info

Publication number
DE60138703D1
DE60138703D1 DE60138703T DE60138703T DE60138703D1 DE 60138703 D1 DE60138703 D1 DE 60138703D1 DE 60138703 T DE60138703 T DE 60138703T DE 60138703 T DE60138703 T DE 60138703T DE 60138703 D1 DE60138703 D1 DE 60138703D1
Authority
DE
Germany
Prior art keywords
protein
amino acid
derived
transportepeptides
rns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60138703T
Other languages
English (en)
Inventor
Johannes Petrus Langedijk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pepscan Systems BV
Original Assignee
Pepscan Systems BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepscan Systems BV filed Critical Pepscan Systems BV
Application granted granted Critical
Publication of DE60138703D1 publication Critical patent/DE60138703D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60138703T 2000-06-28 2001-06-28 Transportpeptide abgeleitet von erns protein Expired - Fee Related DE60138703D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202255A EP1174506A1 (de) 2000-06-28 2000-06-28 C-terminales Erns-Peptide und Analoge davon
PCT/NL2001/000484 WO2002000882A2 (en) 2000-06-28 2001-06-28 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof

Publications (1)

Publication Number Publication Date
DE60138703D1 true DE60138703D1 (de) 2009-06-25

Family

ID=8171710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60138703T Expired - Fee Related DE60138703D1 (de) 2000-06-28 2001-06-28 Transportpeptide abgeleitet von erns protein

Country Status (10)

Country Link
US (2) US7067487B2 (de)
EP (2) EP1174506A1 (de)
JP (1) JP2004501645A (de)
AT (1) ATE431414T1 (de)
AU (2) AU2001269616B2 (de)
CA (1) CA2414308A1 (de)
DE (1) DE60138703D1 (de)
IL (1) IL153600A0 (de)
NZ (1) NZ523231A (de)
WO (1) WO2002000882A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174506A1 (de) 2000-06-28 2002-01-23 Stichting Dienst Landbouwkundig Onderzoek C-terminales Erns-Peptide und Analoge davon
CA2441165A1 (en) 2001-03-16 2002-09-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of binding domains of presenilins and transmembrane proteins for drug screening
AU2003216139B2 (en) 2002-02-01 2008-08-14 Promega Corporation Bioluminescent protease assay
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7416854B2 (en) 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US20090054333A1 (en) * 2006-10-17 2009-02-26 Antonio Giordano Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
WO2008127677A2 (en) 2007-04-13 2008-10-23 Promega Corporation Luminescent live and dead cell assay
DE102008057451A1 (de) * 2008-11-14 2010-05-20 Martin-Luther-Universität Halle-Wittenberg Verfahren zur oralen Vakzinierung mittels rekombinanter Hefen
WO2014165607A2 (en) * 2013-04-02 2014-10-09 Stealth Peptides International, Inc. Aromatic-cationic peptide formulations, compositions and methods of use
GB201322396D0 (en) 2013-12-18 2014-02-05 Univ Nottingham Transduction
AU2016382839A1 (en) * 2015-12-30 2018-06-21 Intervet International B.V. Pestivirus marker vaccine
KR102192471B1 (ko) * 2019-10-18 2020-12-17 주식회사 인코스팜 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888762A (en) * 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
EP0667786B1 (de) * 1992-08-27 2004-01-21 Deakin Research Limited Retro-, inverso-, und retro-inverso synthetische peptidanaloge
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
US5877153A (en) * 1996-06-11 1999-03-02 Commonwealth Biotechnologies Inc. Heparin-binding peptides
US6200955B1 (en) * 1996-06-11 2001-03-13 Commonwealth Biotechnologies, Inc. Heparin binding peptides
IT1286663B1 (it) * 1996-06-27 1998-07-15 Ministero Uni Ricerca Scient E Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
WO1999006569A1 (en) * 1997-07-30 1999-02-11 Stichting Instituut Voor Dierhouderij En Diergezondheid Cytotoxic polypeptide (fragment) derived from ribonuclease
EP0982402A1 (de) * 1998-08-14 2000-03-01 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Pestivirus Impfung
US6865492B2 (en) * 2000-01-24 2005-03-08 The Cielo Institute, Inc. Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
EP1174506A1 (de) 2000-06-28 2002-01-23 Stichting Dienst Landbouwkundig Onderzoek C-terminales Erns-Peptide und Analoge davon

Also Published As

Publication number Publication date
US20060223752A1 (en) 2006-10-05
EP1294891B1 (de) 2009-05-13
AU2001269616B2 (en) 2007-05-17
WO2002000882A2 (en) 2002-01-03
CA2414308A1 (en) 2002-01-03
US7067487B2 (en) 2006-06-27
AU6961601A (en) 2002-01-08
EP1294891A2 (de) 2003-03-26
JP2004501645A (ja) 2004-01-22
EP1174506A1 (de) 2002-01-23
IL153600A0 (en) 2003-07-06
US20030224016A1 (en) 2003-12-04
NZ523231A (en) 2004-09-24
WO2002000882A3 (en) 2002-06-27
US7435721B2 (en) 2008-10-14
ATE431414T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
ATE449965T1 (de) Diagnostisches und therapeutisches epitop
DE69412243D1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
DE60138703D1 (de) Transportpeptide abgeleitet von erns protein
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE69703449D1 (de) Neuroaktive peptide
ATE368053T1 (de) Antimikrobielle peptide
ES550943A0 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
ATE514716T1 (de) Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE69534738D1 (de) Leukocyten-aktivierender Faktor
ATE393777T1 (de) Tachykininpeptide, ihre präpeptide und sie kodierende gene
TH43074A (th) โปรตีนเชื่อมกลูโคสดีไฮโดรจีเนส และการใช้ของมันในระบบการแสดงลักษณะ
DK53290A (da) Syntetiske gaer-leader-peptider
TH18599EX (th) ยาที่เป็นโปรตีนและเพทไทด์ดัดแปลง
TH62241A (th) ไบคูนินของคน

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee